Elisa Agostinetto: Association between hormonal contraceptives and breast cancer risk in BRCA1 carriers

Elisa Agostinetto shared a post on X:

“Out in Journal of Clinical Oncology:

A pooled analysis of data from 4 prospective cohort studies showed that hormonal contraceptives were associated with increased risk of breast cancer in BRCA1 mutation carriers, especially when used for longer durations.”

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2

Authors: Kelly-Anne Phillips, Joanne Kotsopoulos, Susan M. Domchek, Mary Beth Terry, James A. Chamberlain, Julie K. Bassett, Amber M. Aeilts, Irene L. Andrulis, Saundra S. Buys, Wanda Cui, Mary B. Daly, Andrea F. Eisen, William D. Foulkes, Michael L. Friedlander, Jacek Gronwald, John L. Hopper, Esther M. John, Beth Y. Karlan, Raymond H. Kim, Allison W. Kurian, Jan Lubinski, Kelly Metcalfe, Katherine L. Nathanson, Christian F. Singer, Melissa C. Southey, Heather Symecko, Nadine Tung, Steven A. Narod, Roger L. Milne

Elisa Agostinetto, is a medical oncologist, specializing in breast cancer research. Elisa Agostinetto is a Medical Research Fellow at the University Hospital of Brussels since November 2021. Additionally, she has serves as a Clinical Research Fellow at Jules Bordet Institute. Her work focuses on clinical research in oncology, likely involving various aspects of cancer treatment and patient care. Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.